Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
28.71
-0.77 (-2.61%)
At close: Oct 13, 2026, 4:00 PM EDT
27.82
-0.89 (-3.10%)
After-hours: Oct 13, 2026, 6:40 PM EDT
Immunovant Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Immunovant stock has a consensus rating of "Buy" and an average price target of $48.88. The average 1-year stock price forecast is 70.25% higher than the current stock price, while the lowest is $30 (+4.49%) and the highest is $66 (+129.89%).
Price Target: $48.88 (+70.25%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immunovant stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $45 | Buy | Maintains | $45 | +56.74% | Oct 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $53 | Buy | Maintains | $53 | +84.60% | Sep 26, 2026 |
| Bernstein | Bernstein | Hold Maintains $37 | Hold | Maintains | $37 | +28.87% | Sep 26, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $41 | Buy | Maintains | $41 | +42.81% | Sep 23, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
36.81M
EPS This Year
-2.84
from -2.47
EPS Next Year
-2.75
from -2.84
EPS and Forward PE are based on non-GAAP adjusted numbers.